'Pharma Bro' Martin Shkreli accused of violating court order by dealing in pharmaceuticals again

Advertisement

Brief Summary

The FTC and a posse of seven state attorneys general are dragging Martin 'Pharma Bro' Shkreli back to court, accusing him of treating a lifetime pharmaceutical industry ban like a VIP pass to a casino. According to the feds, Shkreli isn't just buying and selling pharma stocks — he's doing it with the subtlety of a halftime show, broadcasting his picks on social media and even live-streaming his transactions for maximum legal insult.

Why This Matters

If you weren't paying attention to Shkreli's antics, this matters because it tests the teeth of court-ordered bans against a defendant who treats the law like a suggestion box. If the judge rules in favor, it signals that clever tech-savvy rebellion won't shield you from consequences — a fresh warning for anyone in finance, health, or tech who thinks they can dodge the rules with a livestream and a smirk. For the average reader hitting rising drug prices, it's a grim reminder that the system sometimes lets the biggest vultures circle round again, forcing taxpayers to fund the cleanup.

Advertisement